Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 1759 Records) |
Query Trace: Adenocarcinoma and EGFR[original query] |
---|
Investigation of EGFR and ALK mutation frequency and treatment results in advanced non-small cell lung cancer. Journal of cancer research and therapeutics 2023 5 19 (Supplement): S183-S190. Berna Komurcuoglu, Gamze Karakurt, Ozge O Kaya, Gulden Diniz, Ozgür K?rb?y?k, Aysen Evkan, Enver Yaln |
Infection with human cytomegalovirus, Epstein-Barr virus, and high-risk types 16 and 18 of human papillomavirus in EGFR-mutated lung adenocarcinoma. Croatian medical journal 2023 5 64 (2): 84-92. Suzana Harabajsa, Hajdi Šef?i?, Marija Klasi?, Marija Milavi?, Snježana Židovec Lepej, Ivana Grgi?, Matea Zajc Petranovi?, Marko Jakopovi?, Silvana Smojver-Ježek, Petra Kor |
Genomic characteristics and prognosis of lung cancer patients with MSI-H: A cohort study. Lung cancer (Amsterdam, Netherlands) 2023 5 181 107255. Jie Tian, Hongdan Wang, Conghua Lu, Lan Liu, Xianquan Zhang, Yunbo Xie, Rutian Li, Xin Lv, Dan Fu, Ling Zhang, Xisheng Fang, Xuming Wang, Jing Hu, Xinyi Liu, Xiaochun Huang, Qian Zhao, Nuo Luo, Huan Tang, Zhaoyang Zhong, Yong He, Li |
Lung adenocarcinoma with EGFR gene mutation metastatic to the uterine cervix: A case report: Erratum. Medicine 2023 5 102 (21): e33976. Authors are not available |
Complete response to first-line osimertinib monotherapy in a complex epidermal growth factor receptor mutant ( L833V / H835L ) lung adenocarcinoma patient : a case report. Anti-cancer drugs 2023 5 . Zhilin Luo, Chengwen Luo, Runquan Zhou, Yajie Xiao, Tianhu Wa |
Advanced Non-small Cell Lung Cancer: EGFR Mutation Analysis Using Pyrosequencing and the Fully Automated qPCR-Based Idylla System. Cancer control : journal of the Moffitt Cancer Center 2023 5 30 10732748231177538. Youssra Boustany, Abdelilah Laraqui, Sara El Zaitouni, Merieme Ghaouti, Asmae Benzekri, Fouad Kettani, Mohammed Oukabli, Khalid Ennibi, Bouchra Belkadi, Yassine Sekhso |
Efficacy and safety analysis of anlotinib combined with PD-1 inhibitors in advanced non-small cell lung cancer: a retrospective cohort study. Journal of thoracic disease 2023 5 15 (4): 2003-2011. Xuanting Ye, Aimi Huang, Yan Zhou, Yanbin Kuang, Weimin Wang, Aiqin Gu, Ling |
Utilisation Patterns and Treatment Outcomes of EGFR-Tyrosine Kinase Inhibitors in EGFR-mutant Advanced Lung Carcinoma in the Pakistani-Asian Population: A Real-world Data Study. Journal of cancer & allied specialties 2023 5 9 (1): 491. Kiran Munawar, Romena Qazi, Hassan Shahryar Shei |
FDG PET texture indices as imaging biomarkers for epidermal growth factor receptor mutation status in lung adenocarcinoma. Scientific reports 2023 5 13 (1): 6742. Mariko Ishimura, Takashi Norikane, Katsuya Mitamura, Yuka Yamamoto, Yuri Manabe, Mitsumasa Murao, Makiko Murota, Nobuhiro Kanaji, Yoshihiro Nishiya |
The Unique Genetic Mutation Characteristics Based on Large Panel Next-Generation Sequencing (NGS) Detection in Multiple Primary Lung Cancers (MPLC) Patients. Discovery medicine 2023 5 35 (175): 131-143. Zhu Liang, Guoxiong Zeng, Wang Wan, Biao Deng, Chunyuan Chen, Fasheng Li, Guanzhou Lin, Yuying Lin, Haitao Lin, Guixi Mo, Huilai Mi |
T790M and Acquired Resistance of Epidermal Growth Factor Receptor to Tyrosine Kinase Inhibitors in Patients with Lung Adenocarcinoma. Tanaffos 2023 4 21 (3): 376-383. Mirtavoos-Mahyari Hanifeh, Abbasi Dezfouli Azizollah, Esfahani-Monfared Zahra, Khosravi Adnan, Seifi Sharareh, Sheikhy Kamb |
Mutant-allele dispersion correlates with prognosis risk in patients with advanced non-small cell lung cancer. Journal of cancer research and clinical oncology 2023 4 . Chen-Xu Wang, Jie Yan, Shan Lin, Yi Ding, Yan-Ru Q |
Molecular Tumor Board Case Series: Targeted Treatments For Cancer And Their Toxicities: Amivantamab-Induced Linear IgA Bullous Dermatosis. Missouri medicine 2023 4 120 (2): 151-154. Lindsey Douglass, Beth Gustafson, Janakiraman Subramani |
Differences in Pleural Fluid Amylase Levels in Patients with Malignant Pleural Effusion Based on Cancer Type, Histologic Type, and Epidermal Growth Factor Receptor Mutations. Internal medicine (Tokyo, Japan) 2023 4 . Masafumi Shimoda, Yoshiaki Tanaka, Kozo Morimoto, Kozo Yoshimori, Ken Oh |
Clinical application of the AMOY 9-in-1 panel to lung cancer patients. Lung cancer (Amsterdam, Netherlands) 2023 4 179 107190. Kunimasa Kei, Matsumoto Shingo, Kawamura Takahisa, Inoue Takako, Tamiya Motohiro, Kanzaki Ryu, Maniwa Tomohiro, Okami Jiro, Honma Keiichiro, Goto Koichi, Nishino Kazu |
Local Consolidative Therapy May Have Prominent Clinical Efficacy in Patients with EGFR-Mutant Advanced Lung Adenocarcinoma Treated with First-Line Afatinib. Cancers 2023 4 15 (7): . Tsai Ming-Ju, Hung Jen-Yu, Ma Juei-Yang, Tsai Yu-Chen, Wu Kuan-Li, Lee Mei-Hsuan, Kuo Chia-Yu, Chuang Cheng-Hao, Lee Tai-Huang, Lee Yen-Lung, Huang Chun-Ming, Shen Mei-Chiou, Yang Chih-Jen, Chong Inn-W |
The evolution of lung cancer and impact of subclonal selection in TRACERx. Nature 2023 4 616 (7957): 525-533. Frankell Alexander M, Dietzen Michelle, Al Bakir Maise, Lim Emilia L, Karasaki Takahiro, Ward Sophia, Veeriah Selvaraju, Colliver Emma, Huebner Ariana, Bunkum Abigail, Hill Mark S, Grigoriadis Kristiana, Moore David A, Black James R M, Liu Wing Kin, Thol Kerstin, Pich Oriol, Watkins Thomas B K, Naceur-Lombardelli Cristina, Cook Daniel E, Salgado Roberto, Wilson Gareth A, Bailey Chris, Angelova Mihaela, Bentham Robert, Martínez-Ruiz Carlos, Abbosh Christopher, Nicholson Andrew G, Le Quesne John, Biswas Dhruva, Rosenthal Rachel, Puttick Clare, Hessey Sonya, Lee Claudia, Prymas Paulina, Toncheva Antonia, Smith Jon, Xing Wei, Nicod Jerome, Price Gillian, Kerr Keith M, Naidu Babu, Middleton Gary, Blyth Kevin G, Fennell Dean A, Forster Martin D, Lee Siow Ming, Falzon Mary, Hewish Madeleine, Shackcloth Michael J, Lim Eric, Benafif Sarah, Russell Peter, Boleti Ekaterini, Krebs Matthew G, Lester Jason F, Papadatos-Pastos Dionysis, Ahmad Tanya, Thakrar Ricky M, Lawrence David, Navani Neal, Janes Sam M, Dive Caroline, Blackhall Fiona H, Summers Yvonne, Cave Judith, Marafioti Teresa, Herrero Javier, Quezada Sergio A, Peggs Karl S, Schwarz Roland F, Van Loo Peter, Miedema Daniël M, Birkbak Nicolai J, Hiley Crispin T, Hackshaw Allan, Zaccaria Simone, , Jamal-Hanjani Mariam, McGranahan Nicholas, Swanton Charl |
[Correlation between Immune Microenvironment Features and EGFR Mutation Status ?in Lung Adenocarcinoma]. Zhongguo fei ai za zhi = Chinese journal of lung cancer 2023 4 26 (3): 204-216. Zhu Hongyu, Chen Peng, Dong Guozhang, Meng Fanchen, Xia Zhijun, You Jing, Kong Xiangru, Wu Jintao, Yuan Fangwei, Yu Xinyu, Sun Qinhong, Ji Jinfu, Wang Siwei, Liu Tongyan, Xu L |
Pathogenic genomic alterations in Chinese pancreatic cancer patients and their therapeutical implications. Cancer medicine 2023 3 . Zhao Zhiming, Li Xiaomo, Wang Fei, Xu Yong, Liu Si, Han Quanli, Yang Zhiying, Huang Weiwei, Yin Zhuzeng, Liu Qu, Tan Haidong, Ma Tonghui, Si Shuang, Huang Jia, Yuan Hongling, Li Wei, Liu Ro |
Association Analysis of Maximum Standardized Uptake Values Based on F-FDG PET/CT and EGFR Mutation Status in Lung Adenocarcinoma. Journal of personalized medicine 2023 3 13 (3): . Gao Jianxiong, Shi Yunmei, Niu Rong, Shao Xiaoliang, Shao Xiaon |
Survival outcomes and prognostic factors of lung cancer patients with the MET exon 14 skipping mutation: A single-center real-world study. Frontiers in oncology 2023 3 13 1113696. Gow Chien-Hung, Hsieh Min-Shu, Chen Yi-Lin, Liu Yi-Nan, Wu Shang-Gin, Shih Jin-Yu |
Molecular characteristics of lung adenocarcinoma with respect to patient age at diagnosis. International journal of cancer 2023 3 . Staaf Johan, Aine Mattias, Nacer Deborah F, Planck Maria, Arbajian El |
The diagnostic significance of cerebrospinal fluid cytology and circulating tumor DNA in meningeal carcinomatosis. Frontiers in neurology 2023 3 14 1076310. Di Wei-Ying, Chen Ya-Nan, Cai Yun, Geng Qiang, Tan Yan-Li, Li Chun-Hui, Wang Ya-Nan, Shang Yan-Hong, Fang Chuan, Cheng Shu-J |
Osimertinib as neoadjuvant therapy in patients with EGFR-mutant resectable stage II-IIIB lung adenocarcinoma (NEOS): A multicenter, single-arm, open-label phase 2b trial. Lung cancer (Amsterdam, Netherlands) 2023 3 178 151-156. Lv Chao, Fang Wentao, Wu Nan, Jiao Wenjie, Xu Shidong, Ma Haitao, Wang Jia, Wang Rui, Ji Chunyu, Li Shaolei, Wang Yuzhao, Yan Shi, Lu Fangliang, Pei Yuquan, Liu Yinan, Yang Y |
Distribution and prognostic impact of EGFR and KRAS mutations according to histological subtype and tumor invasion status in pTis-3N0M0 lung adenocarcinoma. BMC cancer 2023 3 23 (1): 248. Ito Masaoki, Miyata Yoshihiro, Kushitani Kei, Ueda Daisuke, Takeshima Yukio, Okada Morihi |
Monitoring of T790M in plasma ctDNA of advanced EGFR-mutant NSCLC patients on first- or second-generation tyrosine kinase inhibitors. BMC cancer 2023 3 23 (1): 234. Huang Chun-Ta, Lin Chih-An, Su Te-Jen, Yang Ching-Yao, Tsai Tzu-Hsiu, Hsu Chia-Lin, Liao Wei-Yu, Chen Kuan-Yu, Ho Chao-Chi, Yu Chong-J |
Clinicopathological characteristics and molecular analysis of lung cancer associated with ciliated muconodular papillary tumor/bronchiolar adenoma. Pathology international 2023 3 . Higashiyama Masahiro, Motoi Noriko, Yotsukura Masaya, Yoshida Yukihiro, Nakagawa Kazuo, Yagishita Shigehiro, Shirasawa Masayuki, Yoshida Tatsuya, Shiraishi Kouya, Kohno Takashi, Ohe Yuichiro, Watanabe Shun-Ic |
Uses of Vascular Endothelial Growth Factor C as a Lung Adenocarcinoma Prognostic Biomarker. World journal of oncology 2023 3 14 (1): 51-59. Chen Shi, Pan Ting Yu, Wu Xiao, Li Tian, Wei Yu, He Hai Lang, Zhou Xian Mei, Wang Qian, Zhu Ji Pi |
Application of the Novel Grading System of Invasive Pulmonary Adenocarcinoma in a Real Diagnostic Scenario: A Brief Report of 9353 Cases. JTO clinical and research reports 2023 3 4 (3): 100465. She Yunlang, Zhong Yifan, Hou Likun, Zhao Shengnan, Zhang Liping, Xie Dong, Zhu Yuming, Wu Chunyan, Chen Cha |
Different prognostic role of EGFR mutation according to the IASLC histologic grade in patients with resected early-stage lung adenocarcinoma. Histopathology 2023 2 . Hong Tae Hee, Hwang Soohyun, Choi Yoon-La, Lee Genehee, Park Sehhoon, Ahn Myung-Ju, Lee Yoonseo, Jeon Yeong Jeong, Lee Junghee, Shin Sumin, Park Seong Yong, Cho Jong Ho, Choi Yong Soo, Kim Jhingook, Shim Young Mog, Cho Juhee, Kim Hong Kw |
- Page last reviewed:Feb 1, 2023
- Page last updated:Jun 02, 2023
- Content source: